Definition, aims, and implementation of GA2LEN Urticaria Centers of Reference and Excellence

Background GA²LEN, the Global Allergy and Asthma European Network, has recently launched a program for the development, interaction, and accreditation of centers of reference and excellence in special areas of allergy embedded in its overall quality management of allergy centers of excellence. The f...

Full description

Saved in:
Bibliographic Details
Published inAllergy (Copenhagen) Vol. 71; no. 8; pp. 1210 - 1218
Main Authors Maurer, M., Metz, M., Bindslev‐Jensen, C., Bousquet, J., Canonica, G. W., Church, M. K., Godse, K. V., Grattan, C. E., Hide, M., Kocatürk, E., Magerl, M., Makris, M., Meshkova, R., Saini, S. S., Sussman, G., Toubi, E., Zhao, Z., Zuberbier, T., Gimenez‐Arnau, A.
Format Journal Article
LanguageEnglish
Published Zurich Blackwell Publishing Ltd 01.08.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background GA²LEN, the Global Allergy and Asthma European Network, has recently launched a program for the development, interaction, and accreditation of centers of reference and excellence in special areas of allergy embedded in its overall quality management of allergy centers of excellence. The first area chosen is urticaria. Urticaria is a common and debilitating condition and can be a challenge for both patients and treating physicians, especially when chronic. Centers of reference and excellence in urticaria (UCAREs) can help to improve the management of hard‐to‐treat conditions such as urticaria. Aims Here, we describe the aims, the requirements and deliverables, the application process, and the audit and accreditation protocol for GA²LEN UCAREs. Results The main aims of GA²LEN UCAREs are to provide excellence in urticaria management, to increase the knowledge of urticaria by research and education, and to promote the awareness of urticaria by advocacy activities. To become a certified GA²LEN UCARE, urticaria centers have to apply and fulfill 32 requirements, defined by specific deliverables that are assessed during an audit visit. Discussion and Conclusion The GA²LEN UCARE program will result in a strong network of urticaria specialists, promote urticaria research, and harmonize and improve urticaria management globally.
AbstractList Background GA²LEN, the Global Allergy and Asthma European Network, has recently launched a program for the development, interaction, and accreditation of centers of reference and excellence in special areas of allergy embedded in its overall quality management of allergy centers of excellence. The first area chosen is urticaria. Urticaria is a common and debilitating condition and can be a challenge for both patients and treating physicians, especially when chronic. Centers of reference and excellence in urticaria (UCAREs) can help to improve the management of hard-to-treat conditions such as urticaria. Aims Here, we describe the aims, the requirements and deliverables, the application process, and the audit and accreditation protocol for GA²LEN UCAREs. Results The main aims of GA²LEN UCAREs are to provide excellence in urticaria management, to increase the knowledge of urticaria by research and education, and to promote the awareness of urticaria by advocacy activities. To become a certified GA²LEN UCARE, urticaria centers have to apply and fulfill 32 requirements, defined by specific deliverables that are assessed during an audit visit. Discussion and Conclusion The GA²LEN UCARE program will result in a strong network of urticaria specialists, promote urticaria research, and harmonize and improve urticaria management globally.
Background GA²LEN, the Global Allergy and Asthma European Network, has recently launched a program for the development, interaction, and accreditation of centers of reference and excellence in special areas of allergy embedded in its overall quality management of allergy centers of excellence. The first area chosen is urticaria. Urticaria is a common and debilitating condition and can be a challenge for both patients and treating physicians, especially when chronic. Centers of reference and excellence in urticaria (UCAREs) can help to improve the management of hard‐to‐treat conditions such as urticaria. Aims Here, we describe the aims, the requirements and deliverables, the application process, and the audit and accreditation protocol for GA²LEN UCAREs. Results The main aims of GA²LEN UCAREs are to provide excellence in urticaria management, to increase the knowledge of urticaria by research and education, and to promote the awareness of urticaria by advocacy activities. To become a certified GA²LEN UCARE, urticaria centers have to apply and fulfill 32 requirements, defined by specific deliverables that are assessed during an audit visit. Discussion and Conclusion The GA²LEN UCARE program will result in a strong network of urticaria specialists, promote urticaria research, and harmonize and improve urticaria management globally.
Author Meshkova, R.
Zuberbier, T.
Saini, S. S.
Magerl, M.
Bousquet, J.
Godse, K. V.
Makris, M.
Canonica, G. W.
Church, M. K.
Bindslev‐Jensen, C.
Zhao, Z.
Grattan, C. E.
Kocatürk, E.
Sussman, G.
Toubi, E.
Maurer, M.
Hide, M.
Gimenez‐Arnau, A.
Metz, M.
Author_xml – sequence: 1
  givenname: M.
  surname: Maurer
  fullname: Maurer, M.
  organization: Charité ‐ Universitätsmedizin Berlin
– sequence: 2
  givenname: M.
  surname: Metz
  fullname: Metz, M.
  organization: Charité ‐ Universitätsmedizin Berlin
– sequence: 3
  givenname: C.
  surname: Bindslev‐Jensen
  fullname: Bindslev‐Jensen, C.
  organization: Odense University Hospital
– sequence: 4
  givenname: J.
  surname: Bousquet
  fullname: Bousquet, J.
  organization: Université Versailles St‐Quentin‐en‐Yvelines
– sequence: 5
  givenname: G. W.
  surname: Canonica
  fullname: Canonica, G. W.
  organization: University of Genoa
– sequence: 6
  givenname: M. K.
  surname: Church
  fullname: Church, M. K.
  organization: Charité ‐ Universitätsmedizin Berlin
– sequence: 7
  givenname: K. V.
  surname: Godse
  fullname: Godse, K. V.
  organization: D.Y. Patil School of Medicine
– sequence: 8
  givenname: C. E.
  surname: Grattan
  fullname: Grattan, C. E.
  organization: Norfolk and Norwich University Hospital
– sequence: 9
  givenname: M.
  surname: Hide
  fullname: Hide, M.
  organization: Hiroshima University
– sequence: 10
  givenname: E.
  surname: Kocatürk
  fullname: Kocatürk, E.
  organization: Okmeydani Training and Research Hospital
– sequence: 11
  givenname: M.
  surname: Magerl
  fullname: Magerl, M.
  organization: Charité ‐ Universitätsmedizin Berlin
– sequence: 12
  givenname: M.
  surname: Makris
  fullname: Makris, M.
  organization: Attikon University Hospital
– sequence: 13
  givenname: R.
  surname: Meshkova
  fullname: Meshkova, R.
  organization: Smolensk State Medical University
– sequence: 14
  givenname: S. S.
  surname: Saini
  fullname: Saini, S. S.
  organization: Johns Hopkins University
– sequence: 15
  givenname: G.
  surname: Sussman
  fullname: Sussman, G.
  organization: University of Toronto
– sequence: 16
  givenname: E.
  surname: Toubi
  fullname: Toubi, E.
  organization: The Technion
– sequence: 17
  givenname: Z.
  surname: Zhao
  fullname: Zhao, Z.
  organization: Peking University, First Hospital
– sequence: 18
  givenname: T.
  surname: Zuberbier
  fullname: Zuberbier, T.
  organization: Charité ‐ Universitätsmedizin Berlin
– sequence: 19
  givenname: A.
  surname: Gimenez‐Arnau
  fullname: Gimenez‐Arnau, A.
  organization: Universitat Autònoma
BookMark eNotkE1LAzEQhoNUsK0e_AcLXt022ezm41hqrcKiIPYmhNhMICWbrdkt2n_fbOsc5oPnnRl4J2gU2gAI3RM8Iynm2vsZKSQmV2hMqBS5lLIaoTEmuMrLioobNOm6HcaYJ9UYfT2BdcH1rg2PmXZNl3IwmWv2HhoIvR5I1tpsvSjq1Vu2ib3b6uh0tkwUYjewD7AQIWzhvLv624L3w3iLrq32Hdz91ynaPK8-ly95_b5-XS7qfEeYJLnhwAgtiMGGMimNlJZqhjG1tpCcGmYJlN9WYqNZIcpCcya4YLJilaC8LOkUPVzu7mP7c4CuV7v2EEN6qYjABeWMV1VSzS-qX-fhqPbRNToeFcFqcE4l59TZObWo63NDT5SGYjo
ContentType Journal Article
Copyright 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
Copyright © 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
Copyright_xml – notice: 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
– notice: Copyright © 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
DBID 7T5
H94
K9.
DOI 10.1111/all.12901
DatabaseName Immunology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
DatabaseTitle AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
DatabaseTitleList AIDS and Cancer Research Abstracts

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1398-9995
EndPage 1218
ExternalDocumentID 4110950441
ALL12901
Genre article
GrantInformation_xml – fundername: UCB
– fundername: Takeda
– fundername: Uriach
– fundername: Genentech
– fundername: Novartis
– fundername: Almirall
– fundername: MSD
– fundername: Sanofi
– fundername: UNEV
– fundername: Moxie
GroupedDBID .3N
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
23M
24P
2WC
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8F7
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAKAS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZCM
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHEFC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
AOETA
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DC6
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
E3Z
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
P6G
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
TR2
UB1
V9Y
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
Y6R
ZGI
ZXP
ZZTAW
~IA
~KM
~WT
7T5
H94
K9.
ID FETCH-LOGICAL-j1691-d7e61321d0d3699d99f3a6003ff2973d6f1e4bf90da62842a7687869565837443
IEDL.DBID DR2
ISSN 0105-4538
IngestDate Fri Sep 13 05:48:39 EDT 2024
Sat Aug 24 01:01:47 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-j1691-d7e61321d0d3699d99f3a6003ff2973d6f1e4bf90da62842a7687869565837443
OpenAccessLink http://repositori.upf.edu/bitstream/10230/27113/1/maurer-all-defi.pdf
PQID 1802376755
PQPubID 34098
PageCount 9
ParticipantIDs proquest_journals_1802376755
wiley_primary_10_1111_all_12901_ALL12901
PublicationCentury 2000
PublicationDate August 2016
PublicationDateYYYYMMDD 2016-08-01
PublicationDate_xml – month: 08
  year: 2016
  text: August 2016
PublicationDecade 2010
PublicationPlace Zurich
PublicationPlace_xml – name: Zurich
PublicationTitle Allergy (Copenhagen)
PublicationYear 2016
Publisher Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Ltd
References 2010; 65
2015; 5
2011; 128
2015; 29
2013; 68
2015; 135
2015; 40
2013; 368
2011; 66
2014; 69
2016; 71
2005; 60
2013; 132
2011; 4
2014; 133
2012; 67
2016; 174
2014; 75
2016; 172
References_xml – volume: 65
  start-page: 743
  year: 2010
  end-page: 752
  article-title: Establishing a standardized quality management system for the European Health Network GA LEN
  publication-title: Allergy
– volume: 68
  start-page: 1185
  year: 2013
  end-page: 1192
  article-title: Development, validation, and initial results of the Angioedema Activity Score
  publication-title: Allergy
– volume: 75
  start-page: 88
  year: 2014
  end-page: 93
  article-title: Development of a standardized pulse‐controlled ergometry test for diagnosing and investigating cholinergic urticaria
  publication-title: J Dermatol Sci
– volume: 29
  start-page: 2043
  year: 2015
  end-page: 2045
  article-title: An improved Peltier effect‐based instrument for critical temperature threshold measurement in cold‐ and heat‐induced urticaria
  publication-title: J Eur Acad Dermatol Venereol
– volume: 66
  start-page: 317
  year: 2011
  end-page: 330
  article-title: Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report
  publication-title: Allergy
– volume: 5
  start-page: 29
  year: 2015
  article-title: ASSURE‐CSU: a real‐world study of burden of disease in patients with symptomatic chronic spontaneous urticaria
  publication-title: Clin Transl Allergy
– volume: 71
  start-page: 780
  year: 2016
  end-page: 802
  article-title: The definition, diagnostic testing and management of chronic inducible urticarias – update and revision of the EAACI/GA²LEN/EDF/UNEV 2009 consensus panel recommendations
  publication-title: Allergy
– volume: 368
  start-page: 924
  year: 2013
  end-page: 935
  article-title: Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria
  publication-title: N Engl J Med
– volume: 135
  start-page: 925
  year: 2015
  article-title: Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo‐controlled study
  publication-title: J Invest Dermatol
– volume: 69
  start-page: 868
  year: 2014
  end-page: 887
  article-title: The EAACI/GA LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
  publication-title: Allergy
– volume: 4
  start-page: 45
  year: 2011
  end-page: 46
  article-title: Effects of a novel GA?LEN training program on urticaria on the knowledge of general practitioners in Saudi‐Arabia
  publication-title: World Allergy Organ J
– volume: 133
  start-page: 1365
  year: 2014
  end-page: 1372
  article-title: Development and validation of the Urticaria Control Test: a patient‐reported outcome instrument for assessing urticaria control
  publication-title: J Allergy Clin Immunol
– volume: 67
  start-page: 1289
  year: 2012
  end-page: 1298
  article-title: Development and construct validation of the angioedema quality of life questionnaire
  publication-title: Allergy
– volume: 132
  start-page: 101
  year: 2013
  end-page: 109
  article-title: Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy
  publication-title: J Allergy Clin Immunol
– volume: 128
  start-page: 202
  year: 2011
  end-page: 209
  article-title: Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyreoperoxidase
  publication-title: J Allergy Clin Immunol
– volume: 71
  start-page: 1203
  year: 2016
  end-page: 1209
  article-title: The angioedema quality of life questionnaire (AE‐QoL) – assessment of sensitivity to change and minimal clinically important difference
  publication-title: Allergy
– volume: 174
  start-page: 892
  year: 2016
  end-page: 894
  article-title: ATTENTUS, a German online survey of chronic urticaria patients highlighting the burden of disease, unmet needs and real‐life clinical practice
  publication-title: Br J Dermatol
– volume: 172
  start-page: 56
  year: 2016
  end-page: 63
  article-title: Diagnosis and classification of mastocytosis in non‐specialized versus reference centres: a Spanish Network on Mastocytosis (REMA) study on 122 patients
  publication-title: Br J Haematol
– volume: 40
  start-page: 399
  year: 2015
  end-page: 403
  article-title: Validation of a simplified provocation instrument for diagnosis and threshold testing of symptomatic dermographism
  publication-title: Clin Exp Dermatol
– article-title: Omalizumab for the treatment of chronic spontaneous urticaria: a meta‐analysis of randomized clinical trials
  publication-title: J Allergy Clin Immunol
– volume: 60
  start-page: 1073
  year: 2005
  end-page: 1078
  article-title: A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU‐QoL)
  publication-title: Allergy
SSID ssj0007290
Score 2.2268183
Snippet Background GA²LEN, the Global Allergy and Asthma European Network, has recently launched a program for the development, interaction, and accreditation of...
Background GA²LEN, the Global Allergy and Asthma European Network, has recently launched a program for the development, interaction, and accreditation of...
SourceID proquest
wiley
SourceType Aggregation Database
Publisher
StartPage 1210
SubjectTerms Allergies
angioedema
center
Disease management
excellence
management
Skin
urticaria
Title Definition, aims, and implementation of GA2LEN Urticaria Centers of Reference and Excellence
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fall.12901
https://www.proquest.com/docview/1802376755/abstract/
Volume 71
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3PS8MwFA5jB_Hib3FzSg4ePJjRtUna4mno5pBtB3Gww6AkTQLTrRO3gfjX-5K2c3oSL6UlSQmvec33vbx8QehKxpSxtMWIlhEl1GhGZKwEkYJxwbUJPW2J4mDIeyP6OGbjCrot98Lk-hCbgJv1DPe_tg4u5HLLycVs1rRBFEt9rJCeBURP39JRYRFfAfxAKHh1oSpks3g2LX-gym1s6iaX7j6alN3Kc0pem-uVbKafvxQb_9nvA7RXgE7czkfJIaro7AjtDIpl9WM0uddmmrnkrRsspvMlXDOFp_MyudyW4IXBD22_3xnikX0RkGyBbXAYAKQt20jWuradD7ckAI8naNTtPN_1SHHsAnmxyjlEhRrmeL-lPBXwOFZxbAIBuCgwxh50pbhpaSpN7CnBYXLzBTCWMOJAtBiwXUqDU1TNFpk-QxiqhozJFDgho0JFIqReEJjU80WkuadrqFF-gKTwnWXiNOmsxgyroWtnyeQtV95ISsYCNkycDZN2v-9u6n-veo52AfXwPIuvgaqr97W-AGSxkpduCH0BYkPHkg
link.rule.ids 315,786,790,1382,27957,27958,46329,46753
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3PS8MwFA5DQb34W5xOzcGDBzu6Nklb8DJ0c2q3g2ywg1KSJYHp1onbQPzrfUnbOT2Jl9KSpITXvOb7Xl6-IHQuIkLpoEYdJULiEK2oIyLJHcEp40zpwFWGKLY7rNUj933aL6GrYi9Mpg-xCLgZz7D_a-PgJiC95OV8NKqaKApwn1Vwd2oJ1eO3eFSQR1gAQTgE_DrXFTJ5PIumP3DlMjq100tzCz0XHcuySl6r85moDj5_aTb-t-fbaDPHnbieDZQdVFLpLlpr5yvre-jpRulhavO3LjEfjqdwTSUejov8clOCJxrf1r240cE98yLg2Ryb-DBgSFO2UK21bRsfdlUAHvdRr9noXrec_OQF58WI5zgyUDDNezXpSp9FkYwi7XOARr7W5qwryXRNEaEjV3IG85vHgbQEIQOuRYHwEuIfoJV0kqpDhKFqQKkYAC2khMuQB8T1fT1wPR4q5qoyqhRfIMndZ5pYWTojM0PL6MKaMnnLxDeSgrSADRNrw6Qex_bm6O9Vz9B6q9uOk_iu83CMNgAEsSypr4JWZu9zdQJAYyZO7Xj6AgUhy7Q
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3PS8MwFA5jwvDib3E6NQcPHuzo2iRt8TTc5q9uiDjYYVDSJoHp1g23gfjX-5K2c3oSL6UlSQmvec33vbx8QegiDgilSYNaMvaJRZSkVhwIbsWcMs6k8mypiWK3x-765GFAByV0XeyFyfQhVgE37Rnmf60dfCbUmpPz8biugyhAfTYIcx09pFvP39pRXh5gAQBhEXDrXFZIp_Gsmv6Alevg1MwunW00LPqVJZW81ZeLuJ58_pJs_GfHd9BWjjpxMxsmu6gk0z1U6ebr6vto2JJqlJrsrSvMR5M5XFOBR5Miu1yX4KnCt00nbPdwX78IWDbHOjoMCFKXrTRrTdv2h1kTgMcD1O-0X27urPzcBetVS-dYwpMwyTsNYQuXBYEIAuVyAEauUvqkK8FUQ5JYBbbgDGY3hwNl8XwGTIsC3SXEPUTldJrKI4ShqkdpnAAppIQLn3vEdl2V2A73JbNlFdWKDxDlzjOPjCidFpmhVXRpLBnNMumNqKAsYMPI2DBqhqG5Of571XNUeWp1ovC-93iCNgEBsSyjr4bKi_elPAWUsYjPzGj6AstIymM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Definition%2C+aims%2C+and+implementation+of+GA2LEN+Urticaria+Centers+of+Reference+and+Excellence&rft.jtitle=Allergy+%28Copenhagen%29&rft.au=Maurer%2C+M.&rft.au=Metz%2C+M.&rft.au=Bindslev%E2%80%90Jensen%2C+C.&rft.au=Bousquet%2C+J.&rft.date=2016-08-01&rft.issn=0105-4538&rft.eissn=1398-9995&rft.volume=71&rft.issue=8&rft.spage=1210&rft.epage=1218&rft_id=info:doi/10.1111%2Fall.12901&rft.externalDBID=10.1111%252Fall.12901&rft.externalDocID=ALL12901
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0105-4538&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0105-4538&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0105-4538&client=summon